2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine
C32H34F2N2O — CID 155908932
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine
2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine (PubChem CID 155908932) has the molecular formula C32H34F2N2O and a molecular weight of 500.63 g/mol. Its IUPAC name is 2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine.
Molecular Properties
| Compound Name | 2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine |
|---|---|
| PubChem CID | 155908932 |
| Molecular Formula | C32H34F2N2O |
| Molecular Weight | 500.63 g/mol |
| Exact Mass | 500.26 |
| IUPAC Name | 2-[5-tert-butyl-2-[4-tert-butyl-2-(5-fluoro-2-pyridinyl)-5-methoxyphenyl]phenyl]-3-fluoro-4-methylpyridine |
| SMILES | COc1cc(-c2ccc(C(C)(C)C)cc2-c2nccc(C)c2F)c(-c2ccc(F)cn2)cc1C(C)(C)C |
| InChI | InChI=1S/C32H34F2N2O/c1-19-13-14-35-30(29(19)34)25-15-20(31(2,3)4)9-11-22(25)23-17-28(37-8)26(32(5,6)7)16-24(23)27-12-10-21(33)18-36-27/h9-18H,1-8H3 |
| InChIKey | AMVBMPJAAXPTBK-UHFFFAOYSA-N |
| XLogP | 8.67 |
| TPSA | 35.01 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 3 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 37 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 500.63 |
| LogP ≤ 5 | 8.67 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 3 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155908932 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.